D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 57 Citations 9,842 114 World Ranking 1376 National Ranking 37

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Antibiotics
  • Surgery

His primary scientific interests are in Internal medicine, Antibiotics, Surgery, Microbiology and Antibacterial agent. His Internal medicine research integrates issues from Bacteremia and Intensive care, Intensive care medicine. His work carried out in the field of Intensive care brings together such families of science as Outbreak and Intensive care unit.

His Antibiotics research incorporates elements of Gastroenterology, Vancomycin, Prosthesis and Debridement. His Chemotherapy, Proportional hazards model and Implant study in the realm of Surgery connects with subjects such as Spondylitis. His Microbiology study which covers Acinetobacter baumannii that intersects with Sulbactam.

His most cited work include:

  • Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. (337 citations)
  • Epidemiology and Successful Control of a Large Outbreak Due to Klebsiella pneumoniae Producing ExtendedSpectrum β-Lactamases (310 citations)
  • EMERGENCE AND RAPID SPREAD OF CARBAPENEM RESISTANCE DURING A LARGE AND SUSTAINED HOSPITAL OUTBREAK OF MULTIRESISTANT ACINETOBACTER BAUMANNII (309 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Internal medicine, Surgery, Antibiotics, Microbiology and Bacteremia. The various areas that Javier Ariza examines in his Internal medicine study include Gastroenterology and Intensive care. Javier Ariza regularly ties together related areas like Arthritis in his Surgery studies.

His Antibiotics research is multidisciplinary, incorporating elements of Vancomycin and Implant. His Microbiology study combines topics in areas such as Pseudomonas aeruginosa, Outbreak, Daptomycin and Staphylococcus aureus. His Bacteremia research is multidisciplinary, incorporating perspectives in Mortality rate, Septic arthritis and Endocarditis.

He most often published in these fields:

  • Internal medicine (44.39%)
  • Surgery (34.15%)
  • Antibiotics (30.73%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (44.39%)
  • Microbiology (28.29%)
  • Antibiotics (30.73%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Internal medicine, Microbiology, Antibiotics, Cohort and Surgery. His work on Internal medicine is being expanded to include thematically relevant topics such as Bacteremia. His Bacteremia course of study focuses on Septic arthritis and Surgical debridement.

His Microbiology study integrates concerns from other disciplines, such as Staphylococcus aureus, Gram-negative bacteria and Biofilm. His Cohort study also includes fields such as

  • Implant, which have a strong connection to Proportional hazards model, Comorbidity and Erysipelas,
  • Cellulitis which intersects with area such as Soft tissue, Amputation and Incidence,
  • Complication together with Dexamethasone, Mortality rate, Sepsis, Meningitis and Skin infection. His Surgery research includes elements of Enterococcal infections and Case fatality rate.

Between 2016 and 2021, his most popular works were:

  • The Not-So-Good Prognosis of Streptococcal Periprosthetic Joint Infection Managed by Implant Retention: The Results of a Large Multicenter Study (47 citations)
  • Executive summary of management of prosthetic joint infections. Clinical practice guidelines by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (34 citations)
  • Management of Ventriculoperitoneal Shunt Infections in Adults: Analysis of Risk Factors Associated With Treatment Failure. (29 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Antibiotics
  • Surgery

His primary areas of study are Surgery, Internal medicine, Antibiotics, Bacteremia and Multiple drug resistance. His work on Clinical endpoint and Prosthetic joint as part of general Surgery study is frequently linked to Executive summary, therefore connecting diverse disciplines of science. His work deals with themes such as Debridement, Osteomyelitis and Prosthesis, which intersect with Internal medicine.

He integrates Antibiotics with Superinfection in his research. His research integrates issues of Infective endocarditis, Septic arthritis, Endocarditis and Vertebral osteomyelitis in his study of Bacteremia. His study looks at the intersection of Multiple drug resistance and topics like Antibiotic resistance with Pseudomonas aeruginosa, Colistin, Enterobacter cloacae, Klebsiella pneumoniae and Drug resistance.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

EMERGENCE AND RAPID SPREAD OF CARBAPENEM RESISTANCE DURING A LARGE AND SUSTAINED HOSPITAL OUTBREAK OF MULTIRESISTANT ACINETOBACTER BAUMANNII

Xavier Corbella;Abelardo Montero;Miquel Pujol;M. Angeles Domínguez.
Journal of Clinical Microbiology (2000)

485 Citations

Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci.

Roman Pallares;Francisco Gudiol;Josefina Liñares;Javier Ariza.
The New England Journal of Medicine (1987)

471 Citations

Epidemiology and Successful Control of a Large Outbreak Due to Klebsiella pneumoniae Producing ExtendedSpectrum β-Lactamases

Carmen Peña;Miquel Pujol;Carmen Ardanuy;Asumpta Ricart.
Antimicrobial Agents and Chemotherapy (1998)

470 Citations

Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioannina Recommendations

Javier Ariza;Mile Bosilkovski;Antonio Cascio;Juan D Colmenero.
PLOS Medicine (2007)

414 Citations

Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains

Miquel Pujol;Carmen Peña;Roman Pallares;Javier Ariza.
The American Journal of Medicine (1996)

373 Citations

A Large Multicenter Study of Methicillin–Susceptible and Methicillin–Resistant Staphylococcus aureus Prosthetic Joint Infections Managed With Implant Retention

Jaime Lora-Tamayo;Oscar Murillo;José Antonio Iribarren;Alex Soriano.
Clinical Infectious Diseases (2013)

310 Citations

Evaluation of vancomycin for therapy of adult pneumococcal meningitis.

P F Viladrich;F Gudiol;J Liñares;R Pallarés.
Antimicrobial Agents and Chemotherapy (1991)

290 Citations

Spontaneous pyogenic vertebral osteomyelitis in nondrug users.

Joan M. Nolla;Javier Ariza;Carmen Gómez-Vaquero;Jordi Fiter.
Seminars in Arthritis and Rheumatism (2002)

280 Citations

Specific antibody profile in human brucellosis.

J. Ariza;T. Pellicer;R. Pallarés;A. Foz.
Clinical Infectious Diseases (1992)

275 Citations

Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii

Corbella X;Pujol M;Ayats J;Sendra M.
Clinical Infectious Diseases (1996)

240 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Javier Ariza

Jordi Carratalà

Jordi Carratalà

University of Barcelona

Publications: 42

Jesús Rodríguez-Baño

Jesús Rodríguez-Baño

University of Seville

Publications: 39

Antonio Oliver

Antonio Oliver

Instituto de Salud Carlos III

Publications: 38

Matthew E. Falagas

Matthew E. Falagas

Alfa Institute of Biomedical Sciences

Publications: 36

Josefina Liñares

Josefina Liñares

University of Barcelona

Publications: 35

Jordi Rello

Jordi Rello

Instituto de Salud Carlos III

Publications: 34

David L. Paterson

David L. Paterson

University of Queensland

Publications: 31

Andrej Trampuz

Andrej Trampuz

Charité - University Medicine Berlin

Publications: 30

Fe Tubau

Fe Tubau

Bellvitge University Hospital

Publications: 30

Jerónimo Pachón

Jerónimo Pachón

University of Seville

Publications: 28

Emilio Bouza

Emilio Bouza

Hospital General Universitario Gregorio Marañón

Publications: 26

Germán Bou

Germán Bou

University of A Coruña

Publications: 24

Álvaro Pascual

Álvaro Pascual

Spanish National Research Council

Publications: 22

Sheldon L. Kaplan

Sheldon L. Kaplan

Baylor College of Medicine

Publications: 22

Yehuda Carmeli

Yehuda Carmeli

Israel Ministry of Health

Publications: 21

Francisco Gudiol

Francisco Gudiol

University of Barcelona

Publications: 21

Trending Scientists

Gajendra P. S. Raghava

Gajendra P. S. Raghava

Indraprastha Institute of Information Technology Delhi

Dandapani Sivakumar

Dandapani Sivakumar

Google (United States)

Manuchehr Soleimani

Manuchehr Soleimani

University of Bath

Rolf Hempelmann

Rolf Hempelmann

Saarland University

Victoria F. Samanidou

Victoria F. Samanidou

Aristotle University of Thessaloniki

Massimo Mangino

Massimo Mangino

King's College London

David T. Bilton

David T. Bilton

Plymouth University

Cornelia Lass-Flörl

Cornelia Lass-Flörl

Innsbruck Medical University

Mark D. Holmes

Mark D. Holmes

University of Washington

Jessica A. Turner

Jessica A. Turner

Georgia State University

Samuel J. Gershman

Samuel J. Gershman

Harvard University

Steven R. Thorp

Steven R. Thorp

Alliant International University

David C. Atkins

David C. Atkins

University of Washington

Fred A. Rogosch

Fred A. Rogosch

University of Rochester

Michelle J. Hindin

Michelle J. Hindin

Johns Hopkins University

Peter H. Dederichs

Peter H. Dederichs

Forschungszentrum Jülich

Something went wrong. Please try again later.